Market Overview

Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize

Share:
Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize

Shares of NuVasive, Inc. (NASDAQ: NUVA) spiked after the Financial Times named the company as a potential acquisition target.

A deal seems unlikely and, even if a bid is received, there is little opportunity of it being higher than $60 per share, according to Jefferies.

The Analyst

Jefferies’ Raj Denhoy downgraded NuVasive from Buy to Hold with an unchanged $60 price target.

The Thesis

The NuVasive story remains challenging, with a slowdown in spine and larger players gaining share, Denhoy said in a Tuesday downgrade note.

Although the company’s margins could expand, growth prospects remain bleak — and without them, the stock's valuation appears full, the analyst said. 

NuVasive’s growth has been decelerating steadily over the past several years, Denhoy said. While a sluggish U.S. spine market exerts pressure on NuVasive’s domestic performance, the company continues to witness stiffening competition from new technologies like robotics and larger competitors, he said. 

The company has yet to identify an offering that will hold the fort with the waning of the XLIF procedure, which had previously fueled growth, the analyst said. 

NuVasive’s initiatives to insource manufacturing are delayed and have not resulted in the expected benefits, Denhoy said, adding that the company may experience gross margin expansion through 2019 “as volumes work through inventory."

Price Action

NuVasive shares were down 0.29 percent at $55.96 at the time of publication Tuesday. 

Related Links:

Benzinga's Top Upgrades, Downgrades For February 12, 2019

54 Biggest Movers From Yesterday

Latest Ratings for NUVA

DateFirmActionFromTo
Sep 2019MaintainsSell
Sep 2019MaintainsSell
Aug 2019MaintainsMarket Perform

View More Analyst Ratings for NUVA
View the Latest Analyst Ratings

Posted-In: Jefferies Raj DenhoyAnalyst Color Downgrades Health Care Price Target Analyst Ratings General Best of Benzinga

 

Related Articles (NUVA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SWKSCascendReiterates100.0
IBMWells FargoMaintains140.0
PNCWells FargoMaintains147.0
TWOUDA DavidsonMaintains17.0
IDYAOppenheimerInitiates Coverage On17.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Shutdown Avoided? Stocks Get Early Boost With Activision Blizzard Earnings Later

Mid-Morning Market Update: Markets Open Higher; US Foods Profit Misses Expectations